417 related articles for article (PubMed ID: 30021351)
21. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K
J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
[TBL] [Abstract][Full Text] [Related]
22. MiR-30e-3p Influences Tumor Phenotype through
Gramantieri L; Pollutri D; Gagliardi M; Giovannini C; Quarta S; Ferracin M; Casadei-Gardini A; Callegari E; De Carolis S; Marinelli S; Benevento F; Vasuri F; Ravaioli M; Cescon M; Piscaglia F; Negrini M; Bolondi L; Fornari F
Cancer Res; 2020 Apr; 80(8):1720-1734. PubMed ID: 32015093
[TBL] [Abstract][Full Text] [Related]
23. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway.
Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
[TBL] [Abstract][Full Text] [Related]
24. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.
Baik SH; Lee J; Lee YS; Jang JY; Kim CW
Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708
[TBL] [Abstract][Full Text] [Related]
25. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.
Yan SY; Chen MM; Li GM; Wang YQ; Fan JG
Tumour Biol; 2015 Jun; 36(6):4747-55. PubMed ID: 25647261
[TBL] [Abstract][Full Text] [Related]
26. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
Yang H; Zheng W; Zhao W; Guan C; An J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway.
Li X; Yin X; Bao H; Liu C
Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
[TBL] [Abstract][Full Text] [Related]
29. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
Qadir XV; Han C; Lu D; Zhang J; Wu T
Am J Pathol; 2014 Aug; 184(8):2355-64. PubMed ID: 24911372
[TBL] [Abstract][Full Text] [Related]
30. miR-3682-3p Activated by c-Myc Aggravates the Migration and Stemness in Hepatocellular Carcinoma Cells by Regulating PTEN/PI3K/AKT/β-Catenin Signaling.
Zhang Y; Cai H; Wu MH; Zhu DH; Wang XY; Chen ZY; Yang L; Liu P; Liu Z
Dig Dis; 2023; 41(3):447-457. PubMed ID: 36366818
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
Hu J; Ruan J; Liu X; Xiao C; Xiong J
Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
[TBL] [Abstract][Full Text] [Related]
32. miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
Oncol Rep; 2015 Aug; 34(2):1003-10. PubMed ID: 26045065
[TBL] [Abstract][Full Text] [Related]
33. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
34. MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway.
Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
Biomed Pharmacother; 2019 Oct; 118():109111. PubMed ID: 31336343
[TBL] [Abstract][Full Text] [Related]
35. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS
Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810
[TBL] [Abstract][Full Text] [Related]
37. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
38. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib.
Zhang Y; Pan Q; Shao Z
Hum Cell; 2023 Jan; 36(1):296-311. PubMed ID: 36424471
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-29-3p Regulates Hepatocellular Carcinoma Progression Through NF-κB Pathway.
Ma JH; Bu X; Wang JJ; Xie YX
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115237
[TBL] [Abstract][Full Text] [Related]
40. MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN.
Wang H; Zhao Y; Chen T; Liu G; He N; Hu H
BMB Rep; 2019 May; 52(5):312-317. PubMed ID: 30940319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]